Clinical trials conducted in the Cardiovascular (CV) arena are challenging, first and foremost, due to the variety of underlying disease states and conditions that affect a majority of potential trial participants. In addition to participants coming into the study with multiple co-morbidities, CV studies themselves can be quite complex. Layer these initial complexities with protocol designs that may incorporate a control group, retrospective and prospective elements, long-term follow up, or imaging requirements to support the safety and efficacy of new technology, and a sponsor can easily see the scope of the study becoming much more difficult to manage.
This is why choosing the right Contract Research Organization (CRO) for your CV clinical trial is imperative. Here, we expand on five factors you should consider when choosing a CRO for your CV clinical trial.